|1.||Vitek, Michael P: 8 articles (07/2014 - 07/2007)|
|2.||McKenna, Suzanne E: 4 articles (12/2010 - 07/2007)|
|3.||Laskowitz, Daniel T: 3 articles (03/2013 - 07/2007)|
|4.||Wang, Haichen: 3 articles (03/2013 - 07/2007)|
|5.||Hoane, Michael R: 3 articles (12/2010 - 07/2007)|
|6.||James, Michael L: 2 articles (03/2013 - 04/2012)|
|7.||Sheng, Huaxin: 1 article (07/2014)|
|8.||Li, Fengqiao: 1 article (07/2014)|
|9.||Hong, Jun: 1 article (07/2014)|
|10.||Lu, Miaomiao: 1 article (07/2014)|
|1.||Brain Injuries (Brain Injury)
01/01/2009 - "These combined findings suggest that COG1410 appears to have strong preclinical efficacy when administered following traumatic brain injury (TBI)."
07/01/2007 - "The present study evaluated the preclinical efficacy of COG1410, a small molecule ApoE-mimetic peptide (1410 daltons), following cortical contusion injury (CCI). "
02/15/2009 - "We have previously demonstrated that COG1410, an apoE mimetic peptide, exerts neuroprotective and antiinflammatory effects in a murine model of traumatic brain injury (TBI). "
07/01/2007 - "The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury."
07/01/2007 - "COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury."
|3.||Body Weight (Weight, Body)
|5.||Brain Ischemia (Cerebral Ischemia)
03/01/2013 - "In the current study, we utilized a murine model of transient focal cerebral ischemia and reperfusion to demonstrate that intravenous (IV) administration of COG1410 reduces infarct volume and radiographic progression of infarct, and improves functional outcome as assessed by rotarod when delivered up to 4h after ischemia onset."
02/15/2009 - "COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia."
|1.||Apolipoproteins E (ApoE)
|3.||LDL-Receptor Related Protein 1 (LDL-Receptor Related Protein)
|4.||Proteins (Proteins, Gene)